Review of nutritional status, body composition, and effects of antineoplastic drug disposition

被引:12
作者
Wiernikowski, John T. [1 ]
Bernhardt, Melanie Brooke [2 ]
机构
[1] McMaster Univ, McMaster Childrens Hosp, Dept Paediat, Div Paediat Haematol Oncol, Hamilton, ON, Canada
[2] Baylor Coll Med, Sect Hematol Oncol, Dept Pediat, 1102 Bates St,Suite 1025-17, Houston, TX 77030 USA
关键词
chemotherapy; nutrition; pediatric oncology; pharmacokinetics; PROTEIN-CALORIE MALNUTRITION; ACUTE LYMPHOBLASTIC-LEUKEMIA; TREATMENT-RELATED TOXICITY; MIDDLE-INCOME COUNTRIES; SOUTH-AFRICAN CHILDREN; HIGH-DOSE METHOTREXATE; PEDIATRIC-ONCOLOGY; ALTERNATIVE MEDICINE; MASS INDEX; PHARMACOGENETIC VARIATION;
D O I
10.1002/pbc.28207
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The overall survival for children with cancer in high income countries is excellent. However, there are many disparities that may negatively affect survival, which are particularly problematic in low income countries, such as nutritional status at diagnosis and throughout therapy. Nutritional status as well as concomitant foods, supplements, and medications may play a role in overall exposure and response to chemotherapy. Emerging science around the microbiome may also play a role and should be further explored as a contributor to disease progression and therapeutic response. This article highlights some of these issues and proposes additional areas of research relevant to nutritional status and pharmacology that are needed in pediatric oncology.
引用
收藏
页数:11
相关论文
共 120 条
  • [1] Ardekani Ali M., 2009, Avicenna Journal of Medical Biotechnology, V1, P9
  • [2] Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
    Arthur, Janelle C.
    Perez-Chanona, Ernesto
    Muehlbauer, Marcus
    Tomkovich, Sarah
    Uronis, Joshua M.
    Fan, Ting-Jia
    Campbell, Barry J.
    Abujamel, Turki
    Dogan, Belgin
    Rogers, Arlin B.
    Rhodes, Jonathan M.
    Stintzi, Alain
    Simpson, Kenneth W.
    Hansen, Jonathan J.
    Keku, Temitope O.
    Fodor, Anthony A.
    Jobin, Christian
    [J]. SCIENCE, 2012, 338 (6103) : 120 - 123
  • [3] Asher GN, 2017, AM FAM PHYSICIAN, V96, P101
  • [4] Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)
    Asselin, Barbara L.
    Devidas, Meenakshi
    Wang, Chenguang
    Pullen, Jeanette
    Borowitz, Michael J.
    Hutchison, Robert
    Lipshultz, Steven E.
    Camitta, Bruce M.
    [J]. BLOOD, 2011, 118 (04) : 874 - 883
  • [5] OBESITY AS AN ADVERSE PROGNOSTIC FACTOR FOR PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    BASTARRACHEA, J
    HORTOBAGYI, GN
    SMITH, TL
    KAU, SWC
    BUZDAR, AU
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (01) : 18 - 25
  • [6] Drug interactions in oncology
    Beijnen, JH
    Schellens, JHM
    [J]. LANCET ONCOLOGY, 2004, 5 (08) : 489 - 496
  • [7] Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer
    Bergmann, T. K.
    Brasch-Andersen, C.
    Green, H.
    Mirza, M.
    Pedersen, R. S.
    Nielsen, F.
    Skougaard, K.
    Wihl, J.
    Keldsen, N.
    Damkier, P.
    Friberg, L. E.
    Peterson, C.
    Vach, W.
    Karlsson, M. O.
    Brosen, K.
    [J]. PHARMACOGENOMICS JOURNAL, 2011, 11 (02) : 113 - 120
  • [8] ESSAY What are the consequences of the disappearing human microbiota?
    Blaser, Martin J.
    Falkow, Stanley
    [J]. NATURE REVIEWS MICROBIOLOGY, 2009, 7 (12) : 887 - 894
  • [9] Pharmacokinetic considerations in obesity
    Blouin, RA
    Warren, GW
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (01) : 1 - 7
  • [10] Drug disposition in obesity and protein-energy malnutrition
    Boullata, Joseph I.
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2010, 69 (04) : 543 - 550